About Index Trending news
Lists
Pricing
Rgenix

Rgenix

Rgenix

Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world's first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$33,000,000
Employees

Team size

2
Locations
HQ
$33,000,000 Venture capital (Series B)
Xconomy , FinSMEs

Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK

Health Funding Science
Xconomy

In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer

Health Funding Science